1. Home
  2. GTIM vs IOBT Comparison

GTIM vs IOBT Comparison

Compare GTIM & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.21

Market Cap

12.5M

ML Signal

HOLD

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.06

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTIM
IOBT
Founded
1987
2014
Country
United States
Denmark
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
12.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
GTIM
IOBT
Price
$1.21
$0.06
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.25
AVG Volume (30 Days)
20.4K
6.4M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.77
EPS
0.02
N/A
Revenue
$142,315,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$59.50
N/A
Revenue Growth
3.01
N/A
52 Week Low
$1.10
$0.03
52 Week High
$2.24
$2.79

Technical Indicators

Market Signals
Indicator
GTIM
IOBT
Relative Strength Index (RSI) 61.77 22.09
Support Level $1.16 N/A
Resistance Level $1.29 $0.22
Average True Range (ATR) 0.03 0.02
MACD 0.00 -0.01
Stochastic Oscillator 88.89 7.91

Price Performance

Historical Comparison
GTIM
IOBT

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: